Butin
CAS No. 21913-99-5
Butin( ——— )
Catalog No. M39505 CAS No. 21913-99-5
Butin is a major biologically active flavonoid isolated from the heartwood of Dalbergia odorifera with oral activity, with strong antioxidant, antiplatelet and anti-inflammatory activities. Butin significantly alleviates myocardial infarction and improves heart function, together with prevents diabetes-induced cardiac oxidative damage in rat.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 179 | In Stock |
|
| 5MG | 163 | In Stock |
|
| 10MG | 306 | In Stock |
|
| 25MG | 588 | In Stock |
|
| 50MG | 923 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameButin
-
NoteResearch use only, not for human use.
-
Brief DescriptionButin is a major biologically active flavonoid isolated from the heartwood of Dalbergia odorifera with oral activity, with strong antioxidant, antiplatelet and anti-inflammatory activities. Butin significantly alleviates myocardial infarction and improves heart function, together with prevents diabetes-induced cardiac oxidative damage in rat.
-
DescriptionButin, a major biologically active flavonoid isolated from the Dalbergia odorifera, has strong antioxidant, anti-inflammatory and antiplatelet activities.
-
In VitroCell Viability Assay Cell Line:H9c2 Concentration:12.5, 25, 50 μM Incubation Time:6 h Result:Increased cell survival in a dose-dependent manner.Western Blot Analysis Cell Line:H9c2 Concentration:12.5, 25, 50 μM Incubation Time:6 h Result: Increased the expression of GSH-px, GSH, SOD, CAT and HO-1.Real Time qPCR Cell Line:H9c2 Concentration:12.5, 25, 50 μM Incubation Time:6 h Result:Increased the levels of Nrf2 in the cytoplasm and nucleus in a dose-dependent manner and enhanced the expressions of GSH-px, GSH, SOD, CAT and HO-1.
-
In VivoAnimal Model:C57/BL6J mice induced by STZ Dosage:10, 20, 40 mg/kg; twice a day; 15 days Administration:OralResult:Improved cardiac function, significant increases in LVSP, +dP/dtmax and -dP/dtmin, reduced myocardial infarction area, reduced caspase-3 activity and Bax/Bcl-2 ratio, reduced GSH-px, GSH, SOD, CAT and GR activity.Animal Model:Intracerebral hemorrhage rats Dosage:25, 50 mg/kg; single dose Administration:Intraperitoneal injection (i.p.)Result:Increased the neurological score, significantly reduced the volume of hemorrhagic lesions, significantly reduced the Bax/Bcl-2 ratio and caspase-3 protein expression, and significantly reduced brain tissue inflammatory mediators tumor necrosis factor-α (TNF-α) and interleukin. Reduced levels of 6 (IL-6).
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number21913-99-5
-
Formula Weight272.25
-
Molecular FormulaC15H12O5
-
Purity>98% (HPLC)
-
SolubilityDMSO : 100 mg/mL (367.30 mM; ultraphonic; )
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Duan J, et al. Protective effect of butin against ischemia/reperfusion-induced myocardial injury in diabetic mice: involvement of the AMPK/GSK-3β/Nrf2 signaling pathway. Sci Rep. 2017 Jan 27;7:41491.?
molnova catalog
related products
-
Demethylzeylasteral
Demethylzeylasteral has strong immunosuppressive activity, can be used in the fields of organ transplantation and autoimmune disorders.
-
Atezolizumab
Atezolizumab anti-PD-L1) is a fully humanized IgG1 monoclonal antibody that blocks the interaction of PD-L1 with both PD-1 and B7.1 but not the interaction of PD-L2 with PD-1.
-
2-(2,4-Dihydroxyphen...
2-(2,4-Dihydroxyphenyl)-5,6-methylenedioxybenzofuran (ABF).
Cart
sales@molnova.com